GynTect

Schnell zu einer sicheren Diagnose

Die Neuheit für Diagnostiklabore

GynTect.

GynTect.

Sichere Diagnose

Sie haben Fragen zu GynTect?

Wir helfen weiter!

Welcome at oncgnostics GmbH Jena

Reliable cancer diagnosis

Development of molecular assays based on epigenetic biomarkers which allow early and reliable cancer diagnostics – this is the intention of oncgnostics!

Improve diagnosis

Our products should allow an early detection of diseases to substantially inprove therapy success. Notice: if detected early, almost all cancer cases are curable.

News

If you would like us to keep you informed about news related to our company, please sign in for our quarterly newsletter.

MEDICA and COMPAMED 2019

From 18 to 21 November we attended MEDICA 2019, in Düsseldorf. We were at the joint booth for the industry association medways e.V. in the world's largest trade fair for the medical sector. Record Number of Exhibitors and Visitors This year…
The oncgnostics managers together with Geneo Dx managers and colleagues.

Oncgnostics Expands Business Relations in Asia

Approval for cervical cancer screening test in the Chinese market expected in early 2020 / First contacts in Japan Shanghai/Yokohama/Tokyo/Jena, 1 November 2019 –Our business partner in China, GeneoDx, is about to get approval to commercialise…

oncgnostics GynTect

Our fist product, GynTect®, enables reliable and fast diagnosis of cervical cancer and pre-cancerous stages.

Video in German.